Trial Profile
Phase II clinical study of TY-51924 in patients with acute myocardial infarction - Pilot study -
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs TY 51924 (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Toa Eiyo
- 06 Jun 2016 New trial record